Therapeutic ROS targeting of GADD45γ in the induction of G2/M arrest in primary human colorectal cancer cell lines by cucurbitacin E
Authors:
Open Access
- 24 April 2014
- journal article
- Published by Springer Nature in Cell Death & Disease
- Vol. 5 (4) , e1198
Abstract
Cucurbitacin E (CuE) or α-elaterin is a natural compound previously shown to be an antifeedant as well as a potent chemopreventive agent against several types of cancer. The present study investigated the anticancer effects of CuE on colorectal cancer (CRC) using primary cell lines isolated from five CRC patients in Taiwan, Specifically, we explored the anti-proliferation and cell cycle G2/M arrest induced by CuE in CRC cells. MPM-2 flow cytometry tests show that CuE-treated cells accumulated in metaphase (CuE 2.5–7.5 μM). Results further indicate that CuE produced G2/M arrest as well as the downregulation of CDC2 and cyclin B1 expression and dissociation. Both effects increased proportionally with the dose of CuE; however, the inhibition of proliferation, arrest of mitosis, production of reactive oxygen species (ROS), and loss of mitochondrial membrane potential (ΔΨm) were found to be dependent on the quantity of CuE used to treat the cancer cells. In addition, cell cycle arrest in treated cells coincided with the activation of the gene GADD45(α, β, γ). Incubation with CuE resulted in the binding of GADD45γ to CDC2, which suggests that the delay in CuE-induced mitosis is regulated by the overexpression of GADD45γ. Our findings suggest that, in addition to the known effects on cancer prevention, CuE may have antitumor activities in established CRC.Keywords
This publication has 41 references indexed in Scilit:
- Cucurbitacin E as Inducer of Cell Death and Apoptosis in Human Oral Squamous Cell Carcinoma Cell Line SASInternational Journal of Molecular Sciences, 2013
- Cucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary targetCell Communication and Signaling, 2013
- Targeting caspases in cancer therapeuticsBiological Chemistry, 2013
- Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasionBreast Cancer Research and Treatment, 2012
- TRIM8 modulates p53 activity to dictate cell cycle arrestCell Cycle, 2012
- Cucurbitacin E Induces G2/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes ApoptosisviaFas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 CellsEvidence-Based Complementary and Alternative Medicine, 2012
- Apoptosis Induction in Primary Human Colorectal Cancer Cell Lines and Retarded Tumor Growth in SCID Mice by SulforaphaneEvidence-Based Complementary and Alternative Medicine, 2011
- The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2α in leukemia cellsAnti-Cancer Drugs, 2010
- Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIα is regulated directly by protein phosphatase 2ABiochemical Journal, 2007
- Cucurbitacins, Cell Adhesion Inhibitors from Conobea scoparioidesJournal of Natural Products, 1994